Estado protrombótico en estadios tempranos de la enfermedad de Chagas crónica

Herrera, Ramón N; Díaz, Elba; Pérez, Rossana; Chaín, Sergio; Sant-Yacumo, Roque; Rodríguez, Eduardo; Bianchi, Jorge; Coviello, Alfredo; Miotti, Julio; Flores, Isolina; Serna, Fernando de la; Muntaner, Juan; Berman, Sofía; Luciardi, Héctor.
Rev. esp. cardiol. (Ed. impr.) ; 56(4): 377-382, abr. 2003.
Artículo en Es | IBECS (España) | ID: ibc-28039

Documentos relacionados

  1. Chagas disease cardiomyopathy treatment remains a challenge - Authors' reply.
  2. It takes two to tango: How immune responses and metabolic changes jointly shape cardiac Chagas disease.
  3. Updated review on the pathophysiology of Chagas cardiomyopathy.
  4. Prognosis of chronic Chagas heart disease and other pending clinical challenges.
  5. Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease.
  6. Cost-effectiveness of an exercise-based cardiovascular rehabilitation program in patients with chronic Chagas cardiomyopathy in Brazil: An analysis from the PEACH study.
  7. Prognostic impact of Chagas disease in the United States.
  8. Chagas Cardiomyopathy and Myocardial Sympathetic Denervation.
  9. A note on the the discovery of Chagas' disease.
  10. Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease.